Czapska, M.; Babkiewicz, K.; Pabis, S.; Skórzyńska-Dziduszko, K. Sotagliflozin, an Inhibitor of sodium–glucose Cotransporters 1 and 2 (SGLT1/2), As a New Therapeutic Approach for Patients With Type 1 Diabetes Mellitus. J Educ Health Sport 2018, 8, 335-351.